Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity

Lung Cancer

Volumn 53, Issue 3, 2006, Pages 303-310

  Lu, Yen Shen ^a   Lien, Huan Chun ^a   Yeh, Pei Yen ^a   Kuo, Sung Hsin ^a   Chang, Wen Ching ^a   Kuo, Min Liang ^b   Cheng, Ann Lii ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Chemosensitivity; Glucocorticoid receptor; Glucocorticoids; Non small cell lung cancer

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; DEXAMETHASONE; GEMCITABINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PACLITAXEL;

ADULT; ADVANCED CANCER; ALLERGY; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL GROWTH; CELL TYPE; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; DEXAMETHASONE; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOCORTICOIDS; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LUNG NEOPLASMS; RECEPTORS, GLUCOCORTICOID;

EID: 33746910239     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.05.005     Document Type: Article

References (28)

1. Micha J.P., Rettenmaier M.A., Dillman R., Fraser P., Birk C., and Brown J.V. Single-dose dexamethasone paclitaxel premedication. Gynecol Oncol 69 (1998) 122-124
2. Haskell C.M. Antineoplastic agents. In: Haskell C.M., and Break J.S. (Eds). Cancer treatment. 4th ed. (1995), W. B. Saunders, Philadelphia 105-106
3. Soffietti R., Ruda R., and Mutani R. Management of brain metastases. J Neurol 249 (2002) 1357-1369
4. Sheehan J.P., Sun M.H., Kondziolka D., Flickinger J., and Lunsford L.D. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 98 (2003) 342-349
5. Maranzano E. Radiation-induced emesis: a problem with many open questions. Tumori 87 (2001) 213-218
6. Popiela T., Lucchi R., and Giongo F. Methylprednisolone as palliative therapy for female terminal cancer patients. The methylprednisolone female preterminal cancer study group. Eur J Cancer Clin Oncol 25 (1989) 1823-1829
7. Bruera E., Roca E., Cedaro L., Carraro S., and Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 69 (1985) 751-754
8. Greenberg A.K., Hu J., Basu S., Hay J., Reibman J., Yie T.A., et al. Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. Am J Res Cell Mol Biol 27 (2002) 320-328
9. Gassler N., Zhang C., Wenger T., Schnabel P.A., Dienemann H., Debatin K.M., et al. Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo. Br J Cancer 92 (2005) 1084-1088
10. Herr I., Ucur E., Herzer K., Okouoyo S., Ridder R., Krammer P.H., et al. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Res 163 (2003) 3112-3120
11. Wang H., Li M., Rinehart J.J., and Zhang R. Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy. Clin Cancer Res 10 (2004) 1633-1644
12. Lu Y.S., Lien H.C., Yeh P.Y., Yeh K.H., Kuo M.L., Kuo S.H., et al. Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors. World J Gastroenterol 11 (2005) 6373-6380
13. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., and Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47 (1987) 936-942
14. Harmon J.M., and Thompson E.B. Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-CT. Mol Cell Biol 1 (1981) 512-521
15. Beattie C.W., Hansen N.W., and Thomas P.A. Steroid receptors in human lung cancer. Cancer Res 45 (1985) 4206-4214
16. Chaudhuri P.K., Thomas P.A., Walker M.J., Briele H.A., Das Gupta T.K., and Beattie C.W. Steroid receptors in human lung cancer cytosols. Cancer Lett 16 (1982) 327-332
17. Kaiser U., Hofmann J., Schilli M., Wegmann B., Klotz U., Wedel S., et al. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer 67 (1996) 357-364
18. Vanderbilt J.N., Miesfeld R., Maler B.A., and Yamamoto K.R. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1 (1987) 68-74
19. Gehring U., Mugele K., and Ulrich J. Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells. Mol Cell Endocrinol 36 (1984) 107-113
20. Bloomfield C.D., Smith K.A., Peterson B.A., and Munck A. Glucocorticoid receptors in adult acute lymphoblastic leukemia. Cancer Res 41 (1981) 4857-4860
21. Wells R.J., Mascaro K., Young P.C., and Cleary R.E. Glucocorticoid receptors in the lymphoblasts of patients with glucocorticoid-resistant childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 3 (1981) 259-264
22. Pui C.H., Dahl G.V., Rivera G., Murphy S.B., and Costlow M.E. The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. Leuk Res 8 (1984) 579-585
23. Kerstjens H., Overbeek S., Schouten J., Brand P., and Postma D. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Eur Respir J 6 (1993) 868-876
24. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., and Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 57 (2002) 226-230
25. Chaudhuri R., Livingston E., McMahon A.D., Thomson L., Borland W., and Thomson N.C. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 168 (2003) 1308-1311
26. Garside H., Stevens A., Farrow S., Normand C., Houle B., Berry A., et al. Glucocorticoid ligands specify different interactions with NF-kB by allosteric effects on the glucocorticoid receptor for DNA binding domain. J Biol Chem 279 (2004) 50050-50059
27. Sengupta S., and Wasylyk B. Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucorticoid, androgen, and estrogen receptors. Ann N Y Acad Sci 1024 (2004) 54-71
28. Lu YS, Yeh PY, Chuang SE, Gao M, Kuo ML, Cheng AL. Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-kB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa. J Endocrinol 1006; 188:311-319.